Search for Prognostic Factors Associated With Better Survival in Refractory Cardiac Arrest

Through this retrospective observational study (over 4 years; period analysed: 1st January 2011 to 31st December 2014), we looked for prognostic factors associated with better survival in refractory cardiac arrest by:

* assessing the overall survival rate * evaluating the frequency of intra et extra-hospital events and by comparing these with the survival rate * studying no flow, low flow, rhythm at initial management, troponinemia, lactatemia and blood pH in the different groups.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cardiac Arrest (CA) Cardiovascular Diseases ExtraCorporeal Life Support (ECLS) Heart Arrest Heart Diseases

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU Dijon Bourgogne

Dijon, 21079, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients with in-hospital or out-of-hospital refractory CA who underwent ECLS

Exclusion criteria

CA occurring during cardiac surgery
Age > 75 years or < 18 years

Treatment and study plan

Primary outcomes

Survival rate

Time frame: at baseline
Death rate

Time frame: at baseline

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire Dijon

Other

Registry information

Official study title

Prognostic Factors in Refractory Cardiac Arrest Treated With Extracorporeal Life Support at Dijon CHU

Acronym: Pro-ACR

Important dates

Study start: 2016
Primary completion: 2016
Study completion: 2016
First posted: Aug 24, 2017
Registry last updated: Feb 9, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed